Clinical Trials Browser

Phase 4 × Dexmedetomidine × 90 days × Clear all

NCT04266665 2026-03-25

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Phase 4 Completed

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms